Acessibilidade / Reportar erro

Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different?

Abstracts

BACKGROUND AND OBJECTIVES: The pathogenesis of acute respiratory distress syndrome (ARDS) has been described by the presence of direct (pulmonary) and/or indirect (extrapulmonary) insult to the lung parenchyma. Evidence indicates that the pathophysiology of ARDS may differ according to the type of primary insult. This article presents a brief overview of differences between pulmonary and extrapulmonary ARDS, and discusses the interactions between morpho-functional aspects and response to differents therapies, both in experimental and clinical studies. CONTENTS: This systematic review included clinical and experimental ARDS studies found in MedLine and SciElo databases in the last 20 years. Many researchers acknowledge that experimental pulmonary and extrapulmonary ARDS are not identical with regard to morpho-functional aspects, the response to positive end-expiratory pressure (PEEP), recruitment manoeuvre, prone position and other adjunctive therapies. However, contradictory results have been reported in different clinical studies, which could be attributed to the difficulty of classifying ARDS in one or the other category, and to the assurance regarding the onset, phase and severity of ARDS in all patients. CONCLUSIONS: Heterogeneous ARDS patients are still considered as belonging to one syndrome, and are therefore treated in a similar manner. Thus, it is important to understand the pathophysiology of pulmonary and extrapulmonary ARDS in an attempt to better treat these patients.

pulmonary histology; protective ventilation; recruitment manoeuvre; respiratory mechanics


JUSTIFICATIVA E OBJETIVOS: A patogênese da síndrome do desconforto respiratório agudo (SDRA) tem sido explicada pela presença de uma agressão direta (SDRA pulmonar) e/ou indireta (SDRA extrapulmonar) ao parênquima pulmonar. Evidências indicam que a fisiopatologia da doença pode diferir com o tipo de lesão. O objetivo deste estudo foi apresentar breve revisão das diferenças entre a SDRA pulmonar e a SDRA extrapulmonar e discutir as interações entre os aspectos morfofuncionais e a resposta aos diferentes tratamentos. CONTEÚDO: Esta revisão bibliográfica baseou-se em uma pesquisa sistemática de artigos experimentais e clínicos sobre SDRA incluídos nas bases de dados MedLine e SciElo nos últimos 20 anos. Muitos pesquisadores concordam, com base em estudos experimentais, que a SDRA pulmonar e a SDRA extrapulmonar não são idênticas no que diz respeito aos aspectos morfofuncionais, a resposta à pressão positiva ao final da expiração (PEEP), manobra de recrutamento alveolar, posição prona e outras terapias farmacológicas. Entretanto, os estudos clínicos têm descrito resultados contraditórios, os quais podem ser atribuídos à dificuldade de se classificar a SDRA em uma ou outra etiologia, e de se precisar o início, a fase e a gravidade da SDRA nos pacientes. CONCLUSÕES: Pacientes com SDRA de etiologias distintas perduram sendo considerados como pertencendo a uma mesma síndrome e, assim, são tratados da mesma forma. Logo, é fundamental entender as diferenças fisiopatológicas entre a SDRA pulmonar e extrapulmonar para que a terapia seja mais bem direcionada.

histologia pulmonar; manobra de recrutamento alveolar; mecânica respiratória; ventilação protetora


REVIEW ARTICLE

Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different?*

Cristiane S. N. Baez GarciaI; Paolo PelosiII; Patricia R. M. RoccoIII

IPhD in Sciences by UFRJ, Post-Doctorate in Physiology and Pharmacodynamics by FIOCRUZ, Laboratório de Investigação Pulmonar, Instituto de Biofísica Carlos Chagas Filho, UFRJ

IIMD, Department of Ambient, Health and Safety, University of Insubria, Varese, Italy

IIIAssociated Professor at UFRJ; Doctor in Sciences by the Laboratório de Investigação Pulmonar, Instituto de Biofísica Carlos Chagas Filho, UFRJ

Address for correspondence

SUMMARY

BACKGROUND AND OBJECTIVES: The pathogenesis of acute respiratory distress syndrome (ARDS) has been described by the presence of direct (pulmonary) and/or indirect (extrapulmonary) insult to the lung parenchyma. Evidence indicates that the pathophysiology of ARDS may differ according to the type of primary insult. This article presents a brief overview of differences between pulmonary and extrapulmonary ARDS, and discusses the interactions between morpho-functional aspects and response to differents therapies, both in experimental and clinical studies.

CONTENTS: This systematic review included clinical and experimental ARDS studies found in MedLine and SciElo databases in the last 20 years. Many researchers acknowledge that experimental pulmonary and extrapulmonary ARDS are not identical with regard to morpho-functional aspects, the response to positive end-expiratory pressure (PEEP), recruitment manoeuvre, prone position and other adjunctive therapies. However, contradictory results have been reported in different clinical studies, which could be attributed to the difficulty of classifying ARDS in one or the other category, and to the assurance regarding the onset, phase and severity of ARDS in all patients.

CONCLUSIONS: Heterogeneous ARDS patients are still considered as belonging to one syndrome, and are therefore treated in a similar manner. Thus, it is important to understand the pathophysiology of pulmonary and extrapulmonary ARDS in an attempt to better treat these patients.

Key Words: pulmonary histology, protective ventilation, recruitment manoeuvre, respiratory mechanics.

INTRODUCTIION

Acute lung injury (ALI) and its most severe form, the acute respiratory distress syndrome (ARDS) are characterized by acute respiratory failure, diffuse and bilateral pulmonary infiltrates seen at chest X-ray, reduced pulmonary compliance and the ratio between arterial oxygen partial pressure and fraction of inspired oxygen (P/F) ) < 300 mmHg for ALI and P/F < 200 mmHg for ARDS1. Various clinical and surgical conditions may lead to development of ALI/ARDS. There are two pathogenic pathways: direct injury (pulmonary) that directly affects the pulmonary parenchyma and indirect injury (extrapulmonary) resulting from a systemic inflammatory response1 (Chart 1). Experimental studies have disclosed morpho-functional and therapeutic differences between pulmonary and extrapulmonary ARDS2.3, 4-10 However, clinical findings are contradictory4-10 .


The purpose of this study was to carry out a critical analysis of the differences between pulmonary and extrapulmonary ARDS and to discuss interaction between respiratory mechanics, lung histology and response to different treatments.

EPIDEMIOLOGY

Because of issues related to the definition11 and failure in the diagnostic tests12 I it is difficult to assess incidence of ARDS. Approximately 7% of patients admitted in intensive care units (ICU) develop ARDS, with a mortality rate ranging from 35% to 60%13.

Various clinical studies attempted to demonstrate the incidence of pulmonary and extrapulmonary ARDS as well as identify the correlation between etiology and prognosis. Most studies disclosed a higher prevalence of pulmonary ARDS5,7,14,15, although Eisner et al.16 did not find a difference. Pneumonia is the more frequent cause of direct injury, while sepsis is the most prevalent and lethal cause of indirect injury. Suntharalingam et al.17 showed a higher mortality in pulmonary ARDS, whereas Eisner et al.16 had not found a correlation between the etiology of ARDS and mortality. Angus et al.18 observed that at the end of the first year, patients of pulmonary ARDS presented a worsening in quality of life. Parker et al.19 found that quality of life was similar in patients of pulmonary and extrapulmonary ARDS at three months, however after 12 months, patients with pulmonary ARDS presented a better quality of life.

PATHOPHYSIOLOGY

In pulmonary ARDS the alveolar epithelium is the first structure injured. Injury to the epithelial barrier induces: alveolar edema20, reduction of edema depuration21, decrease in the production and turnover of surfactant22 and fibrosis23. Efficient alveolar epithelial repair can minimize formation of fibrosis as the intact epithelial layer suppresses proliferation of fibroblasts and deposits of the extracellular matrix (ECM)24. Epithelial repair involves various molecular mechanisms including interaction between type II pneumocites and the ECM25.

In extrapulmonary ARDS, the endothelial cell is first injured26 by circulating inflammatory mediators released by the extrapulmonary focus (i.e. peritonitis, pancreatitis). Pulmonary endothelium is a highly specialized tissue having physiological and immunological functions, in addition to storing numberless enzymes, receptors and transduction molecules that interact with one another and with the components of the capillary wall and circulating blood cells27. The alveolar-capillary barrier plays a decisive role in repair and remodeling27.

HISTOLOGY

In pulmonary ARDS, involvement of the pulmonary parenchyma is multifocal, whereas in the extrapulmonary, change is more diffuse and uniform due to the hematogenic distribution of inflammatory mediators. Morphological differences between pulmonary and extrapulmonary ARDS were evaluated in autopsies8 observing the prevalence of alveolar collapse, fibrinous exudate and alveolar wall edema in patients with pulmonary ARDS. Negri et al 28 found a higher number of collagen fibers in the pulmonary parenchyma of patients with pulmonary ARDS when compared with the extrapulmonary, suggesting that remodeling of ECM depends on the initial site of the injury.

MORPHOLOGY

Various studies described the morphological difference at CT scan in patients with pulmonary and extrapulmonary ARDS6,29-31. However, Desai et al.7 reported that there is no tomographic characteristic able to predict the etiology of the injury. Studies with CT scan presented the following limitations: 1) small number of patients; 2) the group with extrapulmonary ARDS includes patients with abdominal sepsis and postoperative of heart surgery that usually progress with left lower lobe collapse and 3) direct and indirect injuries can coexist, making interpretation of the morphological pattern more difficult.

RESPIRATORY MECHANICS

Respiratory mechanics also seems to vary according to the etiology of the injury. Gattinoni et al.5 described that although static elastance of the respiratory system is similar in pulmonary and extrapulmonary ARDS, static elastance of the lung was greater in pulmonary ARDS, while static elastance of the thoracic wall was greater in the extrapulmonary. In this framework Albaiceta et al.33 further demonstrated the role of the thoracic wall in the mechanics of the respiratory system of patients with extrapulmonary ARDS. Therefore, to better characterize the pathophysiological process, an analysis of the respiratory system and of its components, the lung and thoracic wall, becomes essential.

RESPONSE TO THE DIFFERENT VENTILATORY AND PHARMACOLOGICAL THERAPIES

Experimental Studies

In pulmonary and extrapulmonary ARDS therapeutic responses presented contradictory outcomes, probably because of the possible coexistence of direct and indirect injuries in the same patients.9,34. To avoid such limitations, experimental models of pulmonary and extrapulmonary ARDS have been developed. In this context Menezes et al.2 developed with mice, models of pulmonary and extrapulmonary ALI induced by intratracheal and intraperitoneal administration of E. coli lipopolysaccharides, respectively with similar levels of mechanical changes at the early stage. They found that the direct injury provoked a more accentuated inflammatory response than the indirect2, notwithstanding that the amount of collagen fibers had been similar in both models. Santos et al.3 when making a temporal study of pulmonary parenchyma remodeling, in these models of pulmonary and extrapulmonary ALI observed that direct injury caused fibroblastogenesis, whereas indirect injury only brings about an early fibrosis that was repaired. Therefore, the balance between alveolar epithelial inflammation and/or endothelial injury and the repair mechanisms, apparently determines the prognosis of ALI/ARDS. Since inflammatory response was different between pulmonary and extrapulmonary ALI , Rocco et al.35 analyzed the role of corticosteroids in these models and found that the steroid (metyilprednisolone) attenuated morphological changes as well as pulmonary inflammatory response, only in the group of pulmonary ALI but avoided changes in the content of collagen fibers in both groups.

Effects of recruitment maneuvers (RM) or positive expiratory end pressure (PEEP) in the pulmonary function and gas exchange also have been studied in different models of ALI 36-39. Most studies reported that RM are more beneficial in extrapulmonary ALI, than in the pulmonary. Kloot et al.36 observed that high levels of PEEP caused a more effective recruitment in the ALI model induced by oleic acid (extrapulmonary) than in that produced by bacteria (pulmonary). Recently, Riva et al.39 investigated the effects of RM on pulmonary mechanics and histology and oxygenation in experimental models of pulmonary and extrapulmonary ALI with similar transpulmonary pressures. They observed that RM improved oxygenation and pulmonary mechanics and decreased alveolar collapse more effectively in extrapulmonary ALI than in the pulmonary; suggesting that efficacy of RM differs according to the injury's etiology39.

Clinical Studies

Results of RM on patients with ARDS remain controversial. Gattinoni et al.5 report that for recruitment of collapsed alveoli PEEP was less efficient in the pulmonary ARDS. Likewise, Pelosi et al. observed beneficial effects of three breaths per minute with a plateau pressure of 45 cmH2O in extrapulmonary ARDS40. Lim et al.41 to substantiate these findings showed that a better oxygenation obtained through alveolar RM in extrapulmonary ARDS was about five times greater than in the pulmonary. Tugrul et al.42 observed that although, lung insufflation sustained at 45 cmH2O for 30 seconds, associated to application of PEEP after insufflation of approximately 16 cmH2O improved extrapulmonary and pulmonary ARDS oxygenation, whereas static compliance increased only in the extrapulmonary ARDS42.

On the other hand, Estenssoro et al.43 found responses similar to alveolar recruitment in patients with pulmonary and extrapulmonary ARDS. To substantiate such results Thille et al.44 conducted a multicentric study and proved that the response to alveolar recruitment with PEEP was no different between pulmonary and extrapulmonary ARDS. This suggests that injury etiology does not influence the recruiting capacity of the alveoli. However, this study measured the pressure of the airways instead of the transpulmonary pressure. In extrapulmonary ARDS, for the same pressure in the airways, due to the high intra-abdominal pressure transpulmonary pressure is low, favoring alveolar recruitment. On the other hand in pulmonary ARDS there is a predominance of alveolar consolidation. As such, for the same airways pressure, transpulmonary pressure is relatively high with a low recruitment potential (Figure 1). Within this framework, Grasso et al.45 reported that efficacy of recruitment maneuvers would be influenced by the elastic properties of the lung and of the thoracic wall, independent of ARDS etiology.


Functional response of extrapulmonary and pulmonary ARDS also differs because of the patient's position in bed. Various authors observed that the ventral decubitus (prone position) produced better oxygenation in the pulmonary than in the extrapulmonary ARDS46,47. This beneficial effect ceased when patients were placed in dorsal decubitus. Pachl et al.48, when assessing the effects of HFOV (high-frequency oscillatory ventilation) suggested that patients with pulmonary ARDS have less recruitable pulmonary tissue. Although response to recruitment maneuvres and to the prone position remain controversial, there is consensus that the ventilatory strategy with low tidal volume must be used in ALI/ARDS independent of the injury's etiology16.

Response to pharmacological therapies also differs for pulmonary and extrapulmonary ARDS. Rialp et al.49 observed that the prone position brought about better oxygenation independent of ARDS etiology, however the beneficial effects to inhalation of nitric oxide (NO) were only observed in patients with pulmonary ARDS. On the other hand, Gerlach et al.50 showed that for pulmonary and extrapulmonary ARDS there was no difference in the effects of NO inhalation on oxygenation. Nevertheless, Domenighetti et al.51 reported that treatment with prostacyclin (PGI2) aerosol reduced mean pulmonary arterial pressure without changes in oxygenation. When patients with pulmonary and extrapulmonary ARDS were separately analyzed, the authors reported a better oxygenation in extrapulmonary ARDS when compared to pulmonary 51.

The controversies in different clinical studies may be ascribed to: 1) difficulty in separating the two types of direct and indirect injuries that may coexist; 2) different stages of injury; 3) different transpulmonary pressures; 4) use of vasoactive drugs that may affect cardiac output and gas exchange; 5) type of RM applied; 6) position adopted (supine, superolateral and prone) during the study;7) method for measuring beneficial effects of pulmonary recruitment; 8) different causes of pulmonary and extrapulmonary ARDS and 9) clinical and ventilatory handling at the time of the study. That is why well controlled experimental studies with animals are important to standardize and clarify such controversial matters. Certainly experimental data cannot be directly extrapolated to a clinical scenario, yet they can be extremely useful to design appropriate clinical studies.

CONCLUSION

ARDS can be divided into pulmonary or extrapulmonary if the primary injury is epithelial or endothelial. Results of pharmacological and ventilatory treatment of pulmonary and extrapulmonary ARDS continue to be controversial. However, use of adequate methods for assessment of respiratory mechanics and pulmonary histology may reduce the existing controversies about response to ventilatory and pharmacological therapies. To enhance clinical handling and increase survival of ARDS patients, it might be necessary to differentiate not only pulmonary and extrapulmonary ARDS, but also the different etiologies of ARDS.

REFERENCES

  • 01. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994;149:818-824.
  • 02. Menezes SL, Bozza PT, Neto HC, et al. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol, 2005;98:1777-1783.
  • 03. Santos FB, Nagato LK, Boechem NM, et al. Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. J Appl Physiol, 2006;100:98-106.
  • 04. Artigas A, Bernard GR, Carlet J, et al. The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med, 1998;157:1332-1347.
  • 05. Gattinoni L, Pelosi P, Suter PM, et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med, 1998;158:3-11.
  • 06. Desai SR, Wells AU, Rubens MB, et al. Acute respiratory distress syndrome: CT abnormalities at long-term follow up. Radiology, 1999;210:29-35.
  • 07. Desai SR, Wells AU, Suntharalingam G, et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary injury: a comparative CT study. Radiology, 2001;218:689-693.
  • 08. Hoelz C, Negri EM, Lichtenfels AJ, et al. Morphometric differences in pulmonary lesions in primary and secondary ARDS. A preliminary study in autopsies. Pathol Res Pract, 2001;197:521-530.
  • 09. Pelosi P, D'Onofrio D, Chiumello D, et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J, 2003;42:48s-56s.
  • 10. Rouby JJ - Recruitment in pulmonary and extrapulmonary acute respiratory distress syndrome: the end of a myth? Anesthesiology, 2007;106:203-204.
  • 11. Villar J, Perez-Mendez L, Lopez J, et al. An early PEEP/FiO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med, 2007;176:795-804.
  • 12. Ware LB - Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med, 2005;33:(Suppl3):S217-S222.
  • 13. Vincent JL, Sakr Y, Ranieri VM - Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med, 2003;31:(Suppl4):S296-S299.
  • 14. Takeda S, Ishizaka A, Fujino Y, et al. Time to change diagnostic criteria of ARDS: towards the disease entity-based subgrouping. Pulm Pharmacol Ther, 2005;18:115-119.
  • 15. Agarwal R, Aggarwal AN, Gupta D, et al. Etiology and outcomes of pulmonary and extrapulmonary acute lung injury/ARDS in a respiratory ICU in North India. Chest, 2006;130:724-729.
  • 16. Eisner MD, Thompson T, Hudson LD, et al. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med, 2001;164:231-236.
  • 17. Suntharalingam G, Regan K, Keogh BF, et al. Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndrome. Crit Care Med, 2001;29:562-566.
  • 18. Angus DC, Musthafa AA, Clermont G, et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med, 2001;163:1389-1394.
  • 19. Parker CM, Heyland DK, Groll D, et al. Mechanism of injury influences quality of life in survivors of acute respiratory distress syndrome. Intensive Care Med, 2006;32:1895-1900.
  • 20. Wiener-Kronish JP, Albertine KH, Matthay MA - Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest, 1991;88:864-867.
  • 21. Modelska K, Pittet JF, Folkesson HG, et al. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med, 1999;160:1450-1456.
  • 22. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med, 1999;160:1843-1850.
  • 23. Bitterman PB - Pathogenesis of fibrosis in acute lung injury. Am J Med, 1992;92:39S-43S.
  • 24. Adamson IY, Young L, Bowden DH - Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol, 1988;130:377-383.
  • 25. Geiser T - Idiopathic pulmonary fibrosisa disorder of alveolar wound repair? Swiss Med Wkly, 2003;133:405-411.
  • 26. Zimmerman GA, Albertine KH, Carveth HJ, et al. Endothelial activation in ARDS. Chest, 1999;116:(Suppl1):18S-24S.
  • 27. Orfanos SE, Mavrommati I, Korovesi I, et al. Pulmonary endothelium in acute lung injury: from- basic science to the critically ill. Intensive Care Med, 2004;30:1702-1714.
  • 28. Negri EM, Hoelz C, Barbas CS, et al. Acute remodeling of parenchyma in pulmonary and extrapulmonary ARDS. An autopsy study of collagen-elastic system fibers. Pathol Res Pract, 2002;198:355-361.
  • 29. Winer-Muram HT, Steiner RM, Gurney JW, et al. Ventilator-associated pneumonia in patients with adult respiratory distress syndrome: CT evaluation. Radiology, 1998;208:193-199.
  • 30. Goodman LR, Fumagalli R, Tagliabue P, et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlation. Radiology, 1999;213:545-552.
  • 31. Rouby JJ, Puybasset L, Cluzel P, et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. II. Physiological correlation and definition of an ARDS Severity Score. CT Scan ARDS Study Group. Intensive Care Med, 2000;26:1046-1056.
  • 32. Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med, 2006;354:1775-1786.
  • 33. Albaiceta GM, Taboada F, Parra D, et al. Differences in the deflation limb of the pressure-volume curves in acute respiratory distress syndrome from pulmonary and extrapulmonary origin. Intensive Care Med, 2003;29:1943-1949.
  • 34. Rocco PR, Pelosi P - Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality? Curr Opin Crit Care, 2008;14:50-55.
  • 35. Rocco PR, Leite-Junior JH, Bozza PT, et al. Effects of corticosteroid on lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. Proc Am Thorac Soc, 2006;3:838.
  • 36. Kloot TE, Blanch L, Melynne Youngblood A, et al. Recruitment maneuvers in three experimental models of acute lung injury. Effect on lung volume and gas exchange. Am J Respir Crit Care Med, 2000;161:1485-1494.
  • 37. Lim SC, Adams AB, Simonson DA, et al. Intercomparison of recruitment maneuver efficacy in three models of acute lung injury. Crit Care Med, 2004;32:2371-2377.
  • 38. Lim SC, Adams AB, Simonson DA, et al. Transient hemodynamic effects of recruitment maneuvers in three experimental models of acute lung injury. Crit Care Med, 2004;32:2378-2384.
  • 39. Riva DR, Oliveira MG, Rzezinski AF, et al. Recruitment maneuver in pulmonary and extrapulmonary experimental acute lung injury. Crit Care Med, 2008; (in press)
  • 40. Pelosi P, Cadringher P, Bottino N, et al. Sigh in acute respiratory distress syndrome. Am J Respir Crit Care Med, 1999;159:872-880.
  • 41. Lim CM, Jung H, Koh Y, et al. Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment strategy, etiological category of diffuse lung injury, and body position of the patient. Crit Care Med, 2003;31:411-418.
  • 42. Tugrul S, Akinci O, Ozcan PE, et al. Effects of sustained inflation and postinflation positive end-expiratory pressure in acute respiratory distress syndrome: focusing on pulmonary and extrapulmonary forms. Crit Care Med, 2003;31:738-744.
  • 43. Estenssoro E, Dubin A, Laffaire E, et al. Impact of positive end-expiratory pressure on the definition of acute respiratory distress syndrome. Intensive Care Med, 2003;29:1936-1942.
  • 44. Thille AW, Richard JC, Maggiore SM, et al. Alveolar recruitment in pulmonary and extrapulmonary acute respiratory distress syndrome: comparison using pressure-volume curve or static compliance. Anesthesiology, 2007;106:212-217.
  • 45. Grasso S, Mascia L, Del Turco M, et al. Effects of recruiting maneuvers in patients with acute respiratory distress syndrome ventilated with protective ventilatory strategy. Anesthesiology, 2002;96:795-802.
  • 46. Pelosi P, Brazzi L, Gattinoni L - Prone position in acute respiratory distress syndrome. Eur Respir J, 2002;20:1017-1028.
  • 47. Lim CM, Kim EK, Lee JS, et al. Comparison of the response to the prone position between pulmonary and extrapulmonary acute respiratory distress syndrome. Intensive Care Med, 2001;27:477-485.
  • 48. Pachl J, Roubik K, Waldauf P, et al. Normocapnic high-frequency oscillatory ventilation affects differently extrapulmonary and pulmonary forms of acute respiratory distress syndrome in adults. Physiol Res, 2006;55:15-24.
  • 49. Rialp G, Betbesé AJ, Pérez-Márquez M, et al. Short-term effects of inhaled nitric oxide and prone position in pulmonary and extrapulmonary acute respiratory distress syndrome. Am J Respir Crit Care Med, 2001;164:243-249.
  • 50. Gerlach H, Keh D, Semmerow A, et al. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med, 2003;167:1008-1015.
  • 51. Domenighetti G, Stricker H, Waldispuehl B - Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response. Crit Care Med, 2001;29:57-62.
  • Endereço para correspondência:
    Profª Patricia Rieken Macedo Rocco
    Laboratório de Investigação Pulmonar
    Instituto de Biofísica Carlos Chagas Filho, UFRJ
    Centro de Ciências da Saúde
    Avenida Carlos Chagas Filho, s/n, Bloco G-014
    Cidade Universitária, Ilha do Fundão
    21941-902, Rio de Janeiro, RJ
    Fones: (+5521) 2562-6530/ Fax: (+5521) 2280-8193
    E-mail:
  • *
    Recebido do Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, RJ
  • Publication Dates

    • Publication in this collection
      18 July 2008
    • Date of issue
      June 2008

    History

    • Accepted
      08 Apr 2008
    • Received
      06 Mar 2008
    Associação de Medicina Intensiva Brasileira - AMIB Rua Arminda, 93 - Vila Olímpia, CEP 04545-100 - São Paulo - SP - Brasil, Tel.: (11) 5089-2642 - São Paulo - SP - Brazil
    E-mail: rbti.artigos@amib.com.br